Niraparib,abiraterone,Prednisone
Janssen
['brca', 'crpc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)']
magnitude (nira/abi vs abi in 1l mcrpc) interim analysis in brca+ cohort: rpfs: 19.5 vs 10.9 mo (hr:0.55,p=0.0007) os stratified analysis: 29.3 vs 28.6 mo (hr: 0.88) os ipcw analysis: hr 0.54,95% ci 0.33-0.90 time to cytotoxic chemo (hr:0.56, p=0.015)
#gu23 
MD, MSc | @UofTUrology @SUO_YUO Fellow & @IHPMEUofT CEHCR PhD| Previously: @AUB_Lebanon and @MCG_Urology